A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Meindl-Beinker, Nadja M. (Author) , Betge, Johannes (Author) , Gutting, Tobias (Author) , Burgermeister, Elke (Author) , Belle, Sebastian (Author) , Zhan, Tianzuo (Author) , Schulte, Nadine (Author) , Ebert, Matthias (Author) , Härtel, Nicolai (Author)
Format:	Article (Journal) Book/Monograph
Language:	English
Published:	London ; Berlin, Heidelberg BioMed Central ; Springer 21 Mai 2019 Heidelberg Universitätsbibliothek Heidelberg 21 Mai 2019
DOI:	https://doi.org/10.1186/s12885-019-5446-2
Online Access:	Resolving-System, kostenfrei, Volltext: https://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-261845 Resolving-System, kostenfrei, Volltext: http://dx.doi.org/https://doi.org/10.1186/s12885-019-5446-2 Verlag, kostenfrei, Volltext: http://www.ub.uni-heidelberg.de/archiv/26184
Author Notes:	Nadja M. Meindl-Beinker, Johannes Betge, Tobias Gutting, Elke Burgermeister, Sebastian Belle, Tianzuo Zhan, Nadine Schulte, Martin Maenz, Matthias P. Ebert and Nicolai Haertel

A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA) by Meindl-Beinker, Nadja M. (Author) , Betge, Johannes (Author) , Gutting, Tobias (Author) , Burgermeister, Elke (Author) , Belle, Sebastian (Author) , Zhan, Tianzuo (Author) , Schulte, Nadine (Author) , Ebert, Matthias (Author) , Härtel, Nicolai (Author) ,

in: BMC cancer, 19 (2019) Artikel-Nummer 231, 8 Seiten

Verlag, kostenfrei, Volltext

Article (Journal) Online Resource